Application of phantom for dose measurement in interventional therapy for pediatric vascular anomalies
10.13491/j.issn.1004-714X.2023.02.008
- VernacularTitle:应用模体测量儿童脉管性疾病介入术患者剂量
- Author:
Jianyu XU
1
,
2
;
Yingmin CHEN
1
,
2
;
Rui CHEN
1
,
2
;
Ya MA
1
,
2
;
Xiaoshan WANG
1
,
2
;
Junnan LU
3
,
4
Author Information
1. Institute of Radiation Medicine, Shandong First Medical University &
2. Shandong Academy of Medical Sciences, Jinan 250062 China.
3. Children'
4. s Hospital affiliated to Shandong University, Jinan 250062 China.
- Publication Type:Journal Article
- Keywords:
Pediatric vascular anomaly;
Pediatric phantom;
Interventional therapy;
Dose area product;
Organ dose;
Effective dose
- From:
Chinese Journal of Radiological Health
2023;32(2):131-136
- CountryChina
- Language:Chinese
-
Abstract:
Objective To apply a phantom for dose measurement in interventional therapy for pediatric vascular diseases, and calculate the effective dose (E) and conversion coefficient of dose area product (DAP) to E, and to provide a dose reference for studying radiation dose and radiation protection in children. Methods Thermoluminescent dosimeters were placed in the organs of the phantom. Low-, medium-, and high-dose groups were set for three types of vascular anomalies based on the duration of fluoroscopy. Digital subtraction angiography was used to simulate exposure conditions at different dose levels. The organ dose was measured, and the effective dose was calculated. Results For the three groups of vascular anomalies in the head and face, the red bone marrow doses were 8.15, 30.34, and 43.53 mGy, respectively, the effective doses were 12.88, 47.84, and 73.12 mSv, respectively; and the average conversion coefficient of DAP to E was 2.16. For the three groups of vascular anomalies in the trunk, the red bone marrow doses were 2.11, 15.62, and 31.21 mGy, respectively; the effective doses were 12.39, 70.56, and 134.60 mSv, respectively, and the average conversion coefficient of DAP to E was 3.03. For the three groups of vascular anomalies in the lower extremities, the red bone marrow doses were 3.58, 6.50, and 12.28 mGy, respectively, the effective doses were 3.64, 7.04, and 14.85 mSv, respectively, and the average conversion coefficient of DAP to E was 0.73. Conclusion Patient dose and DAP-to-E conversion coefficient are in the following order: vascular anomalies in the trunk > vascular anomalies in the head and face > vascular anomalies in the lower extremities. The dose data obtained can be used to estimate children’s radiation exposure.
